New Frameworks to Assess Value of Cancer Care: Strengths and Limitations
| Title: | New Frameworks to Assess Value of Cancer Care: Strengths and Limitations |
| Author: |
Schnipper, Lowell E.; Bastian, Alex
Note: Order does not necessarily reflect citation order of authors. |
| Citation: | Schnipper, Lowell E., and Alex Bastian. 2016. “New Frameworks to Assess Value of Cancer Care: Strengths and Limitations.” The Oncologist 21 (6): 654-658. doi:10.1634/theoncologist.2016-0177. http://dx.doi.org/10.1634/theoncologist.2016-0177. |
| Full Text & Related Files: |
4912372.pdf (666.5Kb; PDF) 
|
| Abstract: | Confronted with the different clinical impacts of different treatments, the rising cost of cancer care, and the financial burden of high drug prices, several influential professional organizations have developed models with which to assess the clinical benefit and value of cancer treatment regimens. The goal is a system of valuing patient therapies that is aligned with the beneficial impact to the patient and society and that moves away from a fixed cost regardless of clinical circumstances. |
| Published Version: | doi:10.1634/theoncologist.2016-0177 |
| Other Sources: | http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912372/pdf/ |
| Terms of Use: | This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA |
| Citable link to this page: | http://nrs.harvard.edu/urn-3:HUL.InstRepos:27662182 |
| Downloads of this work: |
This item appears in the following Collection(s)
-
HMS Scholarly Articles [20025]
Contact administrator regarding this item (to report mistakes or request changes)
